PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.\', \'Vitalant Research Institute and Department of Laboratory Medicine, University of California San Francisco, University of California San Francisco, California, USA.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.\', \'Chan Zuckerberg Biohub, San Francisco, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/19420862.2021.1893426
?:hasPublicationType
?:journal
  • mAbs
is ?:pmid of
?:pmid
?:pmid
  • 33666135
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.236
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2.
?:type

Metadata

Anon_0  
expand all